Time | Program | Speakers |
09:00~09:50 | Registration | |
09:50~10:00 | Opening remarks | 김동욱(가톨릭대학교) |
| Session-I: Recent advances in Clinical Hematology Chair : 이제환 (울산대학교), 조빈 (가톨릭대학교) | |
10:30~11:00 | Minimal residual disease in acute myeloid leukemia and myelodysplastic syndrome | 조병식(가톨릭의대) |
11:00~11:30 | Recent updates in management of Plasma cell myeloma | 엄현석(국립암센터) |
11:30~12:00 | Biology and Current management for Primary myelofibrosis | 엄기성(가톨릭의대) |
12:00~13:00 | Lunch | |
| Session-II: Translational approaches in Hematology Chair : TBD, 김동욱 (가톨릭대학교) | |
13:00~13:40 | Induction of chemotherapy resistance by changing tumor microenvironment | 이호영(서울대학교 약대) |
13:40~14:20 | Translational hematology research for aging and cell therapy using non-human primate hematopoietic stem cells | 유경록(가톨릭의대) |
14:20~15:00 | Cell fate determinants in leukemic progression | 권혁영(순천향의대) |
15:00~15:15 | Coffee break | |
| Session-III: Updates in Immuno-Oncology: from basic and clinic to industry Chair : TBD, 이석 (가톨릭대학교) | |
15:15~15:45 | Basic Immunology: Harnessing T cells for adoptive cell therapy | 박 윤(한국과학기술원) |
15:45~16:15 | Future treatment options using CAR-T cell: From Clinician’s Perspective | 정낙균(가톨릭의대) |
16:15~16:45 | Practical consideration on manufacturing and commercialization of CAR-T and beyond: From an Industrial Perspective | 김세원(SL-BIGEN) |
16:45 ~ | Closing remarks | |
